Programmed cell death 1 (PD1) checkpoint inhibitors are a group of anticancer drugs that are emerging as a frontline treatment for cancer.
Programmed cell death...
A large research study shows a significantly lower risk of death and improved quality of life when combining heart failure treatments.
It is estimated that...
Researchers investigated the impact of high-dose radiation on the host immune system during cancer treatments.
Over four-fifths of lung cancers are non-small cell lung cancer....
Researchers uncover an easy-to-measure and reliable predictor of survival and unplanned hospitalizations amongst patients suffering from blood cancer.
This quick and easy measure is gait...
While ongoing diagnostic and therapeutic advances have improved survival rates in cancer and cardiovascular disease patients, the prevalence of these complications remains quite high.
In...
A recent study published in Cancer Discovery has highlighted yet another example of how a combination of chemotherapy and immunotherapy could be a way to treat...
A ground-breaking research study has shown the utility of lab-grown pieces of gastrointestinal cancer in predicting outcomes in on-going clinical trials.
Pharmaceutical companies worldwide spend...
The benefits of sentinel lymph node biopsy in treating skin cancer (melanoma) is well established; however, the value of lymph-node dissection, a procedure in...
Recent Comments